RagaAI sells purpose-built AI agent suites for healthcare, life sciences and aerospace, powered underneath by its own RagaAI Prism and Catalyst platforms. The healthcare deployment spans radiology, allergy and clinical trials, is HIPAA compliant, SOC 2 certified and described as FDA ready, and the company claims 75-plus US locations, 150-plus clinics served and a 99.9 percent uptime SLA. A Financial Digital Twin and an ROI calculator sit alongside.
Building the agents on top of your own evaluation stack is the part that matters in this market. Prism and Catalyst exist to test and observe AI systems, and an agent vendor in clinical settings that already owns its evaluation tooling can answer the question every hospital procurement team asks first, which is not what the agent does but how you know when it is wrong.
Pricing is by demo only, with nothing published. The claimed 34 percent revenue lift is the vendor’s own figure and lacks a stated baseline, FDA ready is a positioning phrase rather than a clearance, and a company selling into healthcare, life sciences and aerospace at once is spread across three of the most demanding regulatory regimes there are.
